人体包虫病可分为单房型和多房型,前者由于细粒棘球绦虫的幼虫致病,通称包虫囊肿(Echinococcus cyst,EC),后者则是多房棘球绦虫的幼虫所致,也称泡状棘蚴病(Alveolar hydatid disease,AHD)。这两型均以寄生在肝脏居多,过去一直沿用传统的手术疗法,从本世纪开展化学治疗以来,迄今已筛选出甲苯咪唑(Mebendazole,MBZ)作为一有效的抗包虫药物。本文拟作简略介绍。 Human echinococcosis can be divided into single-chamber type and multi-chamber type, the former due to echinococcus granulosus larvae pathogenic, commonly known as hydatid cyst (Echinococcus cyst, EC), which is caused by larvae of Echinococcus multilocularis, Also known as alveolar hydatid disease (Alveolar hydatid disease, AHD). Both of these two types are mostly parasitic in the liver. In the past, traditional surgical treatment was used. Mebendazole (MBZ) has been screened out as an effective anti-echinococcosis drug since the chemotherapeutics of this century. This article is intended to give a brief introduction.